Celltrion Healthcare’s ‘Herzuma’ had first prescription in Germany
‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, Celltrion Healthcare is actively selling in the world had the first prescription in Germany as it did in the U.K.
Thus, ‘Herzuma’ has been sold in Germany, one of the Big 5 Europea...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.